Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Hearing abnormality and Question mark ear.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 1 | Hearing abnormality |
EDN1 encodes endothelin 1 (212 aa). Endothelins are endothelium-derived vasoconstrictor peptides. Highest expression in Adipose Subcutaneous (64.5 TPM) and Lung (50.7 TPM).
Question mark ears, isolated is associated with mutations in the EDN1 gene on chromosome 6.
The EDN1 protein participates in EDN1, EDN3:EDNRB, EDNRA,EDNRB bind EDNs, and Keratinocyte of granulosum layer differentiates into corneocyte of corneum layer in interfollicular epidermis pathways.
EDN1 is classified as a druggable target (Druggable Genome and Hormone Activity categories) with score 5.8.
Genetic testing for EDN1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for question mark ears, isolated has been reported in the published literature.
No clinical trials have been registered for question mark ears, isolated.
23 publications have been identified in PubMed for question mark ears, isolated. Research spans Case Report / Case Series (45%), Basic Science / Preclinical (18%), and Other (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 45% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 11:32 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
4 |
18% |
Other research | 2 | 9% |
Research summaries | 2 | 9% |
Clinical study results | 2 | 9% |
Testing and diagnosis research | 1 | 5% |
Disease patterns and progression | 1 | 5% |
Lin Y (2026). [PMID: 39846418](https://pubmed.ncbi.nlm.nih.gov/39846418/). *Cleft Palate Craniofac J*. [Review / Meta-Analysis]
McElrath AD (2026). [PMID: 32965901](https://pubmed.ncbi.nlm.nih.gov/32965901/). *Unknown Journal*. [Other]
El Fid K (2026). [PMID: 42003052](https://pubmed.ncbi.nlm.nih.gov/42003052/). *Pediatr Dermatol*. [Case Report / Case Series]
Anastasiadou S (2026). [PMID: 41661286](https://pubmed.ncbi.nlm.nih.gov/41661286/). *Pediatr Surg Int*. [Case Report / Case Series]
Jenzer AC (2026). [PMID: 34283487](https://pubmed.ncbi.nlm.nih.gov/34283487/). *Unknown Journal*. [Other]
Mumtazah A (2026). [PMID: 39988915](https://pubmed.ncbi.nlm.nih.gov/39988915/). *Cleft Palate Craniofac J*. [Case Report / Case Series]
He K (2026). [PMID: 39967307](https://pubmed.ncbi.nlm.nih.gov/39967307/). *Cleft Palate Craniofac J*. [Epidemiology / Natural History]
Fukumoto-Inukai KA (2026). [PMID: 42224036](https://pubmed.ncbi.nlm.nih.gov/42224036/). *J Craniofac Surg*. [Clinical Trial Publication]
Seo D (2026). [PMID: 42206749](https://pubmed.ncbi.nlm.nih.gov/42206749/). *J Craniofac Surg*. [Case Report / Case Series]
Finestone SA (2025). [PMID: 40519136](https://pubmed.ncbi.nlm.nih.gov/40519136/). *Cleft Palate Craniofac J*. [Review / Meta-Analysis]